Return to Perspectives
Client Alerts
June 26, 2014

Advertising Alert: FDA Offers Draft Guidance Concerning the Presentation and Correction of Information on Internet/Social Media Platforms Regarding Prescription Drugs and Medical Devices

In June 2014, FDA released draft guidance to industry concerning the promotion of prescription drugs and medical devices on internet and social media platforms associated with character space limitations, and the voluntary correction of misinformation about these FDA-regulated products disseminated online by independent third-parties.  This alert summarizes key aspects of the draft guidance. 

Media Attachments

Related People

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.